Artificial intelligence (AI) software developer Viz.ai has garnered U.S. Food and Drug Administration (FDA) clearance for its abdominal aortic aneurysm (AAA) detection algorithm.
The algorithm -- called Viz AAA -- is designed to detect and triage suspected AAAs on chest CT angiography (CTA) exams from any type of CT scanner, according to the vendor. The algorithm and clinical workflow tool will be available as part of the company's Aortic Module application for aortic pathology.
